Biotec Pharmacon ASA Owners

Health Care & Life Sciences » Biotechnology | Biotec Pharmacon ASA

Biotec Pharmacon ASA | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

DNB Asset Management AS

259,112

0.54%

07/31/2018

Storebrand Asset Management AS

178,741

0.37%

08/31/2018

View Profile

Address	Siva Innovasjonssenter Tromsø TR 9019 Norway
Employees	-
Website	http://www.biotec.no
Updated	07/08/2019
Biotec Pharmacon ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Beta-Glucans segments. The Enzymes segment consists of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing.